-
Days after participating in vaccine trial, man dies in Bhopal
Last updated on Jan 09, 2021, 05:10 pm
-
A 42-year-old volunteer named Deepak Marawi, from Bhopal in Madhya Pradesh died nearly ten days after he participated in the clinical trial for COVAXIN held at a private hospital, its vice-chancellor said on Saturday.
Dr. Rajesh Kapur, Vice-Chancellor, People's Medical College and Hospital where the trial was conducted said that Marawi had participated in the COVAXIN trial held on December 12, 2020.
-
In this articleAll protocols were followed before the trial: Dr. Kapur Doctor who performed postmortem suspects poisoning: Government official Drugs Controller General of India, Bharat Biotech have been informed 'Marawi was kept under observation,' says Dr. Kapur Family members say Marawi experienced health problems after the trial Activist claims Marawi's consent was not taken for the trial
-
Details
All protocols were followed before the trial: Dr. Kapur
![All protocols were followed before the trial: Dr. Kapur]( "All protocols were followed before the trial: Dr. Kapur")
-
Dr. Kapur said that Marawi had volunteered for the trial and was examined.
He claimed, "All protocols were followed and Marawi's consent was taken before allowing him to participate in the trial."
"It (the vial containing the liquid for trial) comes covered and coded. During the trial, 50 percent of people get the actual injection while the rest are given saline," he said.
-
Quote
Doctor who performed postmortem suspects poisoning: Government official
-
Dr. Ashok Sharma, Director of Madhya Pradesh Medico-Legal Institute said that the doctor who had performed postmortem of the deceased suspects that he died of poisoning. "However, the exact cause of the death would be known from his viscera test," he added.
-
Intimation
Drugs Controller General of India, Bharat Biotech have been informed
![Drugs Controller General of India, Bharat Biotech have been informed]( "Drugs Controller General of India, Bharat Biotech have been informed")
-
Dr. Kapur said, "After Marawi's death on December 21, we informed the Drugs Controller General of India and Bharat Biotech, which is the producer and sponsor of the trial."
The DCGI had last week approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and Bharat Biotech's COVAXIN for restricted emergency use in the country, paving the way for a massive inoculation drive.
-
Quote
'Marawi was kept under observation,' says Dr. Kapur
-
Dr. Kapur said Marawi was kept under observation for 30 minutes after the trial as per the guidelines before he was allowed to go. "We monitored his health for seven to eight days," he claimed. Marawi was a tribal and was working as a laborer.
-
Family
Family members say Marawi experienced health problems after the trial
![Family members say Marawi experienced health problems after the trial]( "Family members say Marawi experienced health problems after the trial")
-
The family members of Marawi said, "When he returned home from the trial he experienced some health problems. He complained of shoulder pain on December 17."
"Two days later, he spewed foam. He refused to see a doctor saying he would be alright in a day or two. When his condition deteriorated, he was rushed to the hospital but he died midway," they added.
-
Quote
Activist claims Marawi's consent was not taken for the trial
-
However, Rachana Dhingra, a Bhopal-based social activist, claimed that neither was Marawi's consent taken for participation in the clinical trial nor was he given any proof of his participation in the exercise. The hospital has denied this charge.
